Line 18: |
Line 18: |
| *Exercise Intolerance | | *Exercise Intolerance |
| *Cough | | *Cough |
− | * Dyspnoea | + | *Dyspnoea |
| *Sudden death due to left atrial tear and pulmonary oedema | | *Sudden death due to left atrial tear and pulmonary oedema |
| ===Clinical Signs=== | | ===Clinical Signs=== |
Line 35: |
Line 35: |
| *Cardiomegaly with dorsal displacement of the trachea | | *Cardiomegaly with dorsal displacement of the trachea |
| *Pulmonary Venous Congestion (Enlarged pulmonary Arteries and Veins) | | *Pulmonary Venous Congestion (Enlarged pulmonary Arteries and Veins) |
− | * Pulmonary Oedema | + | *Pulmonary Oedema |
| Evidence of Right sided congestive heart failure maybe evident in severe cases e.g. distended caudal vena cava, hepatomegaly, ascites, pleural effusions. | | Evidence of Right sided congestive heart failure maybe evident in severe cases e.g. distended caudal vena cava, hepatomegaly, ascites, pleural effusions. |
| | | |
Line 46: |
Line 46: |
| | | |
| ===Electrocardiogram (ECG)=== | | ===Electrocardiogram (ECG)=== |
− | * Enlarged Left Atrium (Wide P Wave) | + | *Enlarged Left Atrium (Wide P Wave) |
| *Enlarged Left Ventricle (Tall R wave, wide QRS complex, shift of mean electrical axis to the left) | | *Enlarged Left Ventricle (Tall R wave, wide QRS complex, shift of mean electrical axis to the left) |
| *Rhythm disturbances - Sinus Tacchycardia, Atrial Fibrillation, Atrial premature complexes,Atrial Tacchycardia. | | *Rhythm disturbances - Sinus Tacchycardia, Atrial Fibrillation, Atrial premature complexes,Atrial Tacchycardia. |
Line 54: |
Line 54: |
| | | |
| ==Treatment== | | ==Treatment== |
− | No treatment is recommended prior to the onset of heart failure. Treatment is aimed at managing congestive heart failure through a combination of drugs. | + | No treatment is recommended prior to the onset of heart failure. Once there is evidence of congestive heart failure, treatment is aimed at its management through a combination of drugs. |
| + | |
| The aims of treatment are to: | | The aims of treatment are to: |
− | # '''Reduce Preload'''
| + | 1. '''Reduce Preload''' |
− | *Diuretics to reduce circulating fluid volume (Frusemide, Benzofluazide, Spironolactone, Amiloride)
| + | ::Diuretics to reduce circulating fluid volume (Frusemide, Benzofluazide, Spironolactone, Amiloride) |
− | *Vasodilators to reduce venous return (Nitrates, ACE inhibitors, Alpha antagonists)
| + | ::Vasodilators to reduce venous return (Nitrates, ACE inhibitors, Alpha antagonists) |
− | # '''Reduce Afterload
| + | 2. '''Reduce Afterload |
− | *Vasodilators to decrease systemic vascular resistance
| + | ::Vasodilators to decrease systemic vascular resistance |
− | **ACE inhibitors e.g. Enalapril, Benzapril, Imidopril ,
| + | :::ACE inhibitors e.g. Enalapril, Benzapril, Imidopril , |
− | **Pimobendan
| + | :::Pimobendan |
− | **Calcium channel blockers e.g. Amlodipine
| + | :::Calcium channel blockers e.g. Amlodipine |
− | **Nitrates e.g. Nitropusside
| + | :::Nitrates e.g. Nitropusside |
− | # '''Enhance Systolic function
| + | 3. '''Enhance Systolic function |
− | *Positive Inotropes to increase cardiac contractility and increase cardiac output.
| + | ::Positive Inotropes to increase cardiac contractility and increase cardiac output. |
− | **Pimobendan
| + | :::Pimobendan |
− | ** Digoxin
| + | :::Digoxin |
− | **Dobutamine
| + | :::Dobutamine |
− | **Xanthines
| + | :::Xanthines |
− | # '''Improve Diastolic function
| + | 4. '''Improve Diastolic function |
− | *Negative Chronotropes to increase the length of diastole (digoxin, atenolol)
| + | ::Negative Chronotropes to increase the length of diastole (digoxin, atenolol) |
− | *Calcium channel blockers to improve relaxation (amlodipine)
| + | ::Calcium channel blockers to improve relaxation (amlodipine) |
− | # '''Control cardiac arrhythmias using anti-arrhythmic drugs
| + | 5. '''Control cardiac arrhythmias using anti-arrhythmic drugs |
| | | |
| ==Prognosis== | | ==Prognosis== |